This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2024 Feb 15;209(4):456-459.

doi: 10.1164/rccm.202310-1736LE.

Updated Prevalence of Lymphangioleiomyomatosis in Europe

Evelyn Lynn^{1

2}, Sarah H Forde², Alessandro N Franciosi^{1

2}, Elisabeth Bendstrup^{3

4}, Marcel Veltkamp^{5

6}, Anne E Wind⁵, Coline H M Van Moorsel⁵, Thomas Kromann Lund⁷, Michael Thomas Durheim^{8

9}, Evelien F H I Peeters¹⁰, Michael P Keane^{1

2}, Cormac McCarthy^{1

2}; Northern European LAM Prevalence Consortium

Collaborators, Affiliations

Collaborators

Northern European LAM Prevalence Consortium:
Marissa O'Callaghan, Amina Jouida, Adriane D M Vorselaars, Michael Perch

Affiliations

¹ Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland.
² School of Medicine, University College Dublin, Dublin, Ireland.
³ Center for Rare Lung Diseases, Department of Respiratory Disease and Allergy, Aarhus University Hospital, Aarhus, Denmark.
⁴ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
⁵ ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands.
⁶ Division of Heart and Lungs and.
⁷ Section for Lung Transplantation, Department of Cardiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
⁸ Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway; and.
⁹ Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
¹⁰ Department of Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.

PMID: 38060201
DOI: 10.1164/rccm.202310-1736LE

Updated Prevalence of Lymphangioleiomyomatosis in Europe

Evelyn Lynn et al. Am J Respir Crit Care Med. 2024.

. 2024 Feb 15;209(4):456-459.

doi: 10.1164/rccm.202310-1736LE.

Authors

Evelyn Lynn^{1

2}, Sarah H Forde², Alessandro N Franciosi^{1

2}, Elisabeth Bendstrup^{3

4}, Marcel Veltkamp^{5

6}, Anne E Wind⁵, Coline H M Van Moorsel⁵, Thomas Kromann Lund⁷, Michael Thomas Durheim^{8

9}, Evelien F H I Peeters¹⁰, Michael P Keane^{1

2}, Cormac McCarthy^{1

2}; Northern European LAM Prevalence Consortium

Collaborators

Northern European LAM Prevalence Consortium:
Marissa O'Callaghan, Amina Jouida, Adriane D M Vorselaars, Michael Perch

Affiliations

¹ Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland.
² School of Medicine, University College Dublin, Dublin, Ireland.
³ Center for Rare Lung Diseases, Department of Respiratory Disease and Allergy, Aarhus University Hospital, Aarhus, Denmark.
⁴ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
⁵ ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands.
⁶ Division of Heart and Lungs and.
⁷ Section for Lung Transplantation, Department of Cardiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
⁸ Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway; and.
⁹ Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
¹⁰ Department of Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.

PMID: 38060201
DOI: 10.1164/rccm.202310-1736LE

No abstract available

PubMed Disclaimer

Comment in

Lymphangioleiomyomatosis: No Longer Ultra-rare.
Gupta N, Johnson SR. Gupta N, et al. Am J Respir Crit Care Med. 2024 Feb 15;209(4):358-359. doi: 10.1164/rccm.202312-2254ED. Am J Respir Crit Care Med. 2024. PMID: 38190704 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information